Literature DB >> 32320658

m.3243A > G-Induced Mitochondrial Dysfunction Impairs Human Neuronal Development and Reduces Neuronal Network Activity and Synchronicity.

Teun M Klein Gunnewiek1, Eline J H Van Hugte2, Monica Frega3, Gemma Solé Guardia1, Katharina Foreman4, Daan Panneman5, Britt Mossink2, Katrin Linda2, Jason M Keller2, Dirk Schubert4, David Cassiman6, Richard Rodenburg7, Noemi Vidal Folch5, Devin Oglesbee5, Ester Perales-Clemente5, Timothy J Nelson8, Eva Morava9, Nael Nadif Kasri10, Tamas Kozicz11.   

Abstract

Epilepsy, intellectual and cortical sensory deficits, and psychiatric manifestations are the most frequent manifestations of mitochondrial diseases. How mitochondrial dysfunction affects neural structure and function remains elusive, mostly because of a lack of proper in vitro neuronal model systems with mitochondrial dysfunction. Leveraging induced pluripotent stem cell technology, we differentiated excitatory cortical neurons (iNeurons) with normal (low heteroplasmy) and impaired (high heteroplasmy) mitochondrial function on an isogenic nuclear DNA background from patients with the common pathogenic m.3243A > G variant of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). iNeurons with high heteroplasmy exhibited mitochondrial dysfunction, delayed neural maturation, reduced dendritic complexity, and fewer excitatory synapses. Micro-electrode array recordings of neuronal networks displayed reduced network activity and decreased synchronous network bursting. Impaired neuronal energy metabolism and compromised structural and functional integrity of neurons and neural networks could be the primary drivers of increased susceptibility to neuropsychiatric manifestations of mitochondrial disease.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MELAS; induced pluripotent stem cells; m.3243A > G; micro-electrode array; mitochondria; mitochondrial disease; network activity; neurodevelopment; neuron

Mesh:

Year:  2020        PMID: 32320658     DOI: 10.1016/j.celrep.2020.107538

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  15 in total

1.  A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.

Authors:  Jiayang Chen; Mary E Lambo; Xia Ge; Joshua T Dearborn; Yating Liu; Katherine B McCullough; Raylynn G Swift; Dora R Tabachnick; Lucy Tian; Kevin Noguchi; Joel R Garbow; John N Constantino; Harrison W Gabel; Keith B Hengen; Susan E Maloney; Joseph D Dougherty
Journal:  Neuron       Date:  2021-10-05       Impact factor: 17.173

2.  Neuropathy-associated Fars2 deficiency affects neuronal development and potentiates neuronal apoptosis by impairing mitochondrial function.

Authors:  Xihui Chen; Fangfang Liu; Bowen Li; Yufeng Wang; Lijuan Yuan; Anan Yin; Qi Chen; Weihong Hu; Yan Yao; Mengjie Zhang; YuanMing Wu; Kun Chen
Journal:  Cell Biosci       Date:  2022-07-06       Impact factor: 9.584

3.  Sensitive quantification of m.3243A>G mutational proportion in non-retinal tissues and its relationship with visual symptoms.

Authors:  Nathaniel K Mullin; Kristin R Anfinson; Megan J Riker; Kelsey L Wieland; Nicole J Tatro; Todd E Scheetz; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

4.  [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.

Authors:  Jelle van den Ameele; Young Hong; Roido Manavaki; Antonina Kouli; Heather Biggs; Zoe MacIntyre; Rita Horvath; Patrick Yu-Wai-Man; Evan Reid; Caroline H Williams-Gray; Ed Bullmore; Franklin Aigbirhio; Tim Fryer; Patrick Chinnery
Journal:  Neurology       Date:  2021-04-21       Impact factor: 9.910

Review 5.  Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish.

Authors:  Suleva Povea-Cabello; Marina Villanueva-Paz; Juan M Suárez-Rivero; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar
Journal:  Front Genet       Date:  2021-01-12       Impact factor: 4.599

Review 6.  Functional Characterization of Human Pluripotent Stem Cell-Derived Models of the Brain with Microelectrode Arrays.

Authors:  Anssi Pelkonen; Cristiana Pistono; Pamela Klecki; Mireia Gómez-Budia; Antonios Dougalis; Henna Konttinen; Iveta Stanová; Ilkka Fagerlund; Ville Leinonen; Paula Korhonen; Tarja Malm
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

Review 7.  Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells.

Authors:  Mario G Pavez-Giani; Lukas Cyganek
Journal:  Front Cell Dev Biol       Date:  2022-01-10

8.  iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.

Authors:  Maike Kosanke; Colin Davenport; Monika Szepes; Lutz Wiehlmann; Tim Kohrn; Marie Dorda; Jonas Gruber; Kaja Menge; Maike Sievert; Anna Melchert; Ina Gruh; Gudrun Göhring; Ulrich Martin
Journal:  Stem Cell Reports       Date:  2021-09-23       Impact factor: 7.765

9.  Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons.

Authors:  Teun M Klein Gunnewiek; Anouk H A Verboven; Iris Pelgrim; Mark Hogeweg; Chantal Schoenmaker; Herma Renkema; Julien Beyrath; Jan Smeitink; Bert B A de Vries; Peter-Bram A C 't Hoen; Tamas Kozicz; Nael Nadif Kasri
Journal:  Stem Cell Reports       Date:  2021-07-29       Impact factor: 7.765

10.  Human neuronal networks on micro-electrode arrays are a highly robust tool to study disease-specific genotype-phenotype correlations in vitro.

Authors:  Britt Mossink; Anouk H A Verboven; Eline J H van Hugte; Teun M Klein Gunnewiek; Giulia Parodi; Katrin Linda; Chantal Schoenmaker; Tjitske Kleefstra; Tamas Kozicz; Hans van Bokhoven; Dirk Schubert; Nael Nadif Kasri; Monica Frega
Journal:  Stem Cell Reports       Date:  2021-07-29       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.